Alain Pluquet joins bioMérieux
This article was originally published in Clinica
French in vitro diagnostics firm bioMérieux has appointed Alain Pluquet chief technology officer. In the newly-created role, Dr Pluquet will be responsible for enhancing the Paris-based company's technology portfolio through in-house programmes, external research partnerships and technology acquisitions. Before joining bioMérieux, he had worked for the French Atomic Energy Commission since 1994, most recently as head of signal and capturing technology at its laboratory for system and technology integration.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.